Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-762922
Filing Date
2016-11-08
Accepted
2016-11-08 15:46:53
Documents
51
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d235119d10q.htm 10-Q 318528
2 EX-31.1 d235119dex311.htm EX-31.1 5990
3 EX-31.2 d235119dex312.htm EX-31.2 6000
4 EX-32.1 d235119dex321.htm EX-32.1 3787
5 EX-32.2 d235119dex322.htm EX-32.2 3795
  Complete submission text file 0001193125-16-762922.txt   2203774

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20160930.xml EX-101.INS 391783
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20160930.xsd EX-101.SCH 30041
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20160930_cal.xml EX-101.CAL 46794
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20160930_def.xml EX-101.DEF 59958
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20160930_lab.xml EX-101.LAB 228071
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20160930_pre.xml EX-101.PRE 154985
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 161981173
SIC: 2834 Pharmaceutical Preparations